NCT02703350View on ClinicalTrials.gov

A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

LY900014

Administered subcutaneously (SC)

DRUG

Insulin Lispro

Administered SC

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Mainz

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT02703350 - A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy | Biotech Hunter | Biotech Hunter